Reduced Natural Killer Function Accompanies MDS Disease Progression and Is Restored by Lenalidomide (CC5013, Revlimid®) Via a Mechanism Divergent from Interleukin-2 (IL-2).

Autor:	Epling-Burnette, P.K., Bai, Fanqi *, Painter, Jeffrey S. *, Dana, Rollison *, Zou, JianXiang *, Ku, Edna, Zhong, Bin *, Wei, Sheng *, Djeu, Julie Y. *, List, Alan F.
Zdroj:	In Blood 16 November 2006 108(11):2651-2651
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu